Orally active, β-lactamase stable, penem antibiotic. Prepn: M. Ishiguro et al., EP 199446; eidem, US 4997829 (1986, 1991 both to Suntory); eidem, J. Antibiot. 41, 1685 (1988). Pharmacokinetics: A. Tsuji et al., Drug Metab. Dispos. 18, 245 (1990). In vitro antimicrobial spectrum: J. M. Woodcock et al., J. Antimicrob. Chemother. 39, 35 (1997). β-Lactamase stability: A. Dalhoff et al., Chemotherapy (Basel) 49, 229 (2003). HPLC determn in plasma: R. V. S. Nirogi et al., Arzneim.-Forsch. 55, 762 (2005). Clinical trial in urinary tract infections: S. Arakawa et al., Nishinihon J. Urol. 56, 300 (1994); in bacterial sinusitis: R. Siegert et al., Eur. Arch. Otorhinolaryngol. 260, 186 (2003).
Prepn: H. Iwata et al., WO 9203442; eidem, US 5830889 (1992, 1998 both to Suntory).
Antibacterial (antibiotics).
Antibacterial (Antibiotics); β-Lactams; Penems